Last CNY21.72 CNY
Change Today +0.19 / 0.88%
Volume 4.3M
300147 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 10/31/14 All times are local (Market data is delayed by at least 15 minutes).

xiangxue pharmaceutical co-a (300147) Snapshot

Open
CNY21.62
Previous Close
CNY21.53
Day High
CNY21.90
Day Low
CNY21.10
52 Week High
02/25/14 - CNY25.06
52 Week Low
12/3/13 - CNY13.15
Market Cap
11.1B
Average Volume 10 Days
5.0M
EPS TTM
CNY0.38
Shares Outstanding
509.6M
EX-Date
07/14/14
P/E TM
57.3x
Dividend
CNY0.12
Dividend Yield
0.57%
Current Stock Chart for XIANGXUE PHARMACEUTICAL CO-A (300147)

Related News

No related news articles were found.

xiangxue pharmaceutical co-a (300147) Related Businessweek News

No Related Businessweek News Found

xiangxue pharmaceutical co-a (300147) Details

Xiangxue Pharmaceutical Co., Ltd. is engaged in the development, production, and distribution of Chinese patent medicines in China and internationally. The company offers Chinese medicines, western medicines, medical devices, and health products, as well as beverages. It also offers antiviral oral liquids for the prevention and treatment of cold under the brand name of Xiangxue; and indigowoad root granules. The company offers its products in the form of tablets, capsules, granules, oral liquids, aerosols, and others. Xiangxue Pharmaceutical Co., Ltd. was founded in 1997 and is based in Guangzhou, China.

Founded in 1997

xiangxue pharmaceutical co-a (300147) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

xiangxue pharmaceutical co-a (300147) Key Developments

Xiangxue Pharmaceutical Co., Ltd. Announces Earnings Results for the First Three Quarters of 2014

Xiangxue Pharmaceutical Co., Ltd. announced earnings results for the first three quarters of 2014. The company revealed operating revenue of CNY 1.145 billion, net profit attributable to shareholders of CNY 152 million and basic EPS of CNY 0.3 in the first three quarters, rising 42.31%, 41.4% and 42.86% from a year earlier respectively, boosted by increasing sales volume.

Xiangxue Pharmaceutical Co., Ltd. Proposes Amendments to Articles of Association

Xiangxue Pharmaceutical Co., Ltd. announced that its Extraordinary General Meeting of 2014 will be held on 11 November 2014, to consider the amendments to the company's articles of association.

Xiangxue Pharmaceutical Co., Ltd. to Report Q3, 2014 Results on Oct 25, 2014

Xiangxue Pharmaceutical Co., Ltd. announced that they will report Q3, 2014 results on Oct 25, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300147:CH CNY21.72 CNY +0.19

300147 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300147.
View Industry Companies
 

Industry Analysis

300147

Industry Average

Valuation 300147 Industry Range
Price/Earnings 54.4x
Price/Sales 7.0x
Price/Book 6.6x
Price/Cash Flow 54.8x
TEV/Sales 5.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XIANGXUE PHARMACEUTICAL CO-A, please visit www.xphcn.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.